CAMP
CAMP4 Therapeutics Corporation
There isn't enough reported data to score CAMP yet.
CAMP Fundamentals
| Metric | Status |
|---|---|
| Unavailable | |
| Weak | |
| Under pressure | |
| Weak |
CAMP's profitability, cash flow and balance sheet are currently under pressure. There isn't enough data to rate its revenue.
CAMP PE Valuation
CAMP has no meaningful PE right now: it lost money over the past year.
CAMP Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Losses shrinking | |
| Strong growth | |
| -- | |
| Limited | |
| Low |
Analysts expect CAMP's losses to shrink, with revenue growing. However, they disagree widely on these estimates.
CAMP Earnings Per Share
CAMP lost $2.13 per share over the past year, a bigger loss than the year before.
CAMP Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $1.9M | +139% |
| Q2 2026 | $1.8M | +19% |
| Q1 2026 | $1.3M | +51% |
| Q3 2023 | $350K | -100% |
| Q2 2023 | $70.9M | +9.5% |
| Q1 2023 | $78.5M | +15% |
| Q4 2022 | $78.9M | +15% |
| Q3 2022 | $72.8M | -7.8% |
CAMP's revenue is recovering but still below its 2020 peak: $2M last quarter, up 139% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | -739% | +978 points |
| Q2 2026 | -752% | +118 points |
| Q1 2026 | -1010% | +517 points |
| Q4 2025 | -3671% | N/A |
| Q3 2025 | -1717% | N/A |
| Q2 2025 | -870% | N/A |
| Q1 2025 | -1527% | N/A |
| Q3 2023 | -3525% | -3518 points |
CAMP's operating margin was −739% last quarter, up 978 points from the same quarter a year ago.
CAMP Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | -$8.9M | +$2.3M |
| Q2 2026 | -$12.8M | -$2.5M |
| Q1 2026 | -$11M | +$3.6M |
| Q4 2025 | $6.3M | +$17.8M |
| Q2 2025 | -$10.3M | +$3.3M |
| Q1 2025 | -$14.6M | -$3.4M |
| Q4 2024 | -$11.6M | +$475K |
| Q2 2024 | -$13.6M | -$10.5M |
CAMP has burned cash in most quarters: −$26M over the past year, against −$48M the year before.
CAMP Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +36% | +21M shares |
| 1 year | +292% | +58.8M shares |
| 3 years | +119% | +42.9M shares |
CAMP has 79M diluted shares, up 292% from a year ago.
| Quarter | Spent |
|---|---|
| Q2 2024 | — |
| Q1 2024 | — |
| Q4 2023 | — |
| Q3 2023 | — |
| Q2 2023 | — |
| Q1 2023 | — |
| Q4 2022 | — |
| Q3 2022 | — |
CAMP Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2021 | 25.3x | High |
| Q2 2021 | 14.1x | High |
| Q1 2021 | 8.2x | High |
| Q4 2020 | 15.9x | High |
| Q3 2020 | 16.1x | High |
| Q2 2020 | 9.9x | High |
| Q1 2020 | 13.2x | High |
CAMP's net debt is more than 20 years of its operating earnings (EBITDA), up from 16 years a year ago.
CAMP Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 50.5 | Neutral |
| Stochastic | 35.4 | Neutral |
CAMP's weekly RSI is 51 (neutral) and its Stochastic is 35 (neutral).
CAMP PE vs Healthcare Sector
CAMP has no meaningful PE right now: it lost money over the past year.
CAMP Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $3.78 | 8.2% above |
| 20 week MA | $4.03 | 1.5% above |
| 50 week MA | $4.39 | 6.8% below |
| 100 week MA | $3.75 | 9.1% above |
CAMP's trend is mixed: it's above three of its four weekly moving averages, and 9.1% above its 100-week average.
CAMP Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2024 | $10.7 | $5.43 | -49% |
| 2025 | $5.43 | $5.96 | +9.8% |
| 2026 YTD | $5.96 | $4.09 | -31% |
CAMP has finished lower in one of the last two years. It's down 31% so far in 2026.